Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

a technology of rna-dependent rna and nucleosides, which is applied in the field of nucleoside compounds, can solve the problems of limited clinical benefit, no established vaccine for hcv, and treatment of hcv infection

Inactive Publication Date: 2005-12-08
BHAT BALKRISHEN +7
View PDF13 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0022] The present invention provides a method for inhibiting RNA-dependent RNA viral polymerase, a method for inhibiting RNA-dependent RNA viral replication, and/or a method for treating RNA-dependent v

Problems solved by technology

Hepatitis C virus (HCV) infection is a major health problem that leads to chronic liver disease, such as cirrhosis and hepatocellular carcinoma, in a substantial number of infected individuals, estimated to be 2-15% of the world's population.
Current treatments for HCV infection, which are restricted to immunotherapy with recombinant interferon-α alone or in combination with the nucleoside analog ribavirin, are of limited clinical benefit.
Moreover, there is no established vaccine for HCV.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
  • Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
  • Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

Examples

Experimental program
Comparison scheme
Effect test

example 1

3′-Deoxyguanosine

[0719]

[0720] This compound was prepared following the procedures described in Nucleosides Nucleotides, 13: 1049 (1994).

example 2

3′-Deoxy-3′-fluoroguanosine

[0721]

[0722] This compound was prepared following the procedures described in J. Med. Chem. 34: 2195 (1991).

example 3

8-Azidoguanosine

[0723]

[0724] This compound was prepared following the procedures described in Chem. Pharm. Bull. 16: 1616 (1968).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and / or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and / or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] The present invention is related to U.S. provisional application Ser. No. 60 / 263,313, filed Jan. 22, 2001; 60 / 282,069, filed Apr. 6, 2001; 60 / 299,320, filed Jun. 19, 2001; and 60 / 344,528 filed Oct. 25, 2001; the contents of each of which are hereby incorporated by reference.FIELD OF THE INVENTION [0002] The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and for the treatment of hepatitis C infection. BACKGROUND OF THE INVENTION [0003] Hepatitis C virus (HCV) infection is a major health problem that leads to chronic liver disease, such as cirrhosis and hepatocellular carcinoma, in a substa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/519A61K31/70A61K31/7052A61K31/706C07D487/04A61K31/7064A61K31/7068A61K31/7076A61K31/708A61K31/7105A61K31/712A61K38/21A61K45/00A61K45/06A61P1/16A61P31/14A61P43/00C07D473/00C07D487/02C07HC07H19/00C07H19/04C07H19/048C07H19/06C07H19/067C07H19/09C07H19/10C07H19/14C07H19/16C07H19/167C07H19/173C07H19/19C07H19/20C12N
CPCA61K31/7056Y02P20/582C07D473/00C07D487/04C07H19/00C07H19/06C07H19/10C07H19/12C07H19/14C07H19/16C07H19/20A61K9/4858A61K31/7076A61K31/7064A61K45/06A61K38/21A61K2300/00A61P1/16A61P31/00A61P31/14A61P43/00
Inventor BHAT, BALKRISHENELDRUP, ANNE B.PRAKASH, THAZHA P.COOK, PHILLIP DANLAFEMINA, ROBERT L.SIMCOE, AMY L.RUTKOWSKI, CARRIE A.VALENCIANO, MARIO A.
Owner BHAT BALKRISHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products